Início › Câncer Colorretal › Maryland › Baltimore
Ensaios clínicos de Câncer Colorretal em Baltimore, MD
31 estudos para Câncer Colorretal estão buscando participantes em locais em Baltimore e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
Family Communications After Genetic Testing
RecrutandoVoluntários saudáveis bem-vindos
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · a 8 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- e mais 2
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecrutandoFase 1
- Exelixis Clinical Site #14, Baltimore
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Greater Baltimore Medical Center, Baltimore
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecrutandoFase 3
- MedStar Franklin Square Medical Center, Baltimore
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecrutandoFase 3
- MedStar Franklin Square Medical Center, Baltimore
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RecrutandoFase 2/3
- Local Institution - 0262, Baltimore
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RecrutandoFase 1
- United Theranostics, Glen Burnie · a 9 mi de distância
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecrutandoFase 1/2
- The Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- Johns Hopkins, Baltimore
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
RecrutandoFase 3
- Saint Agnes Hospital, Baltimore
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
RecrutandoFase 1
- United Theranostics, Glen Burnie · a 9 mi de distância
Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer
RecrutandoFase 1/2
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecrutandoFase 3
- Clinical Study Site, Baltimore
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
RecrutandoFase 2
- Research Site, Baltimore
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
RecrutandoFase 1
- Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RecrutandoFase 1
- Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecrutandoFase 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
RecrutandoFase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecrutandoFase 2
- Johns Hopkins Hospital /ID# 275645, Baltimore
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
RecrutandoFase 4
- Mercy Medical Center, Baltimore
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBar
Recrutando
- Johns Hopkins University, Baltimore
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
RecrutandoFase 1
- Advanced Molecular Imaging and Therapy, Glen Burnie · a 9 mi de distância
- United Theranostics - Chesapeake, Glen Burnie · a 9 mi de distância
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- Johns Hopkins University, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecrutandoFase 1/2
- Johns Hopkins Hospital, Baltimore
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Johns Hopkins University, Baltimore
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
RecrutandoFase 2
- Johns Hopkins SKCCC, Baltimore
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Johns Hopkins University, Baltimore
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
RecrutandoFase 2
- NGM Clinical Study Site, Baltimore
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecrutandoEstudo observacional
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- UM Saint Joseph Medical Center, Towson · a 8 mi de distância
- e mais 1
Ensaios de Câncer Colorretal em outras cidades
- Houston, TX102 estudos
- New York City, NY78 estudos
- Nashville, TN69 estudos
- Boston, MA63 estudos
- Los Angeles, CA59 estudos
- Arlington, VA52 estudos
- St. Louis, MO50 estudos
- San Antonio, TX46 estudos
- Philadelphia, PA44 estudos
- Grand Rapids, MI40 estudos
- Baldwin Park, CA37 estudos
- Chicago, IL34 estudos
Outros estudos em Baltimore
- Câncer de Pulmão de Não Pequenas Células60 estudos
- Câncer de Mama47 estudos
- Câncer de Próstata43 estudos
- Câncer de Pulmão40 estudos
- Câncer (todos os tipos)37 estudos
- Câncer de Pâncreas31 estudos
- Câncer Metastático28 estudos
- Obesidade26 estudos
- Câncer de Bexiga24 estudos
- Insuficiência Cardíaca24 estudos
- Câncer de Ovário22 estudos
- Acidente Vascular Cerebral21 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.